Stay updated with breaking news from Segments Profiled. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global progressive multifocal leukoencephalopathy treatment market is expected to garner a market value of US$ 1,320 million in 2023 and is expected to accumulate a market value of US$ 1,773.97 million by registering a CAGR of 3% in the forecast period 2023 to 2033. The market for progressive multifocal leukoenc...
During the forecast period 2023 to 2033, the Rosai-Dorfman Disease (RDD) Therapeutics market is expected to grow at a value of 6.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Rosai-Dorfman Disease (RDD) Therapeutics is expected to rise up to a market valuation of US$ 839.95 Mi...
A recently published study by FMI expects the global Central Pain Syndrome Management Market to augment at a 5% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 100 Billion is expected for the market. As per the World Health Organization (WHO), the share of the world’s population...
According to Future Market Insights, the global Hyperglycemia Treatment Market is expected to grow at a CAGR of 12.3% between 2023 and 2033, reaching US$ 1,596 Million in 2033. With the growing number of young people prone to stress levels and poor eating habits, hyperglycemia treatments have become more popular. Ac...
During the forecast period 2023-2033, the Healthcare Companion Robots Market is expected to grow at a value of 18% CAGR, according to Future Market Insights. By the year 2033, the global market for healthcare companion robots is expected to rise up to a market valuation of US$ 11.73 Billion. Companion robots are cre...